Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-031646
Filing Date
2025-06-16
Accepted
2025-06-16 17:30:33
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750109427.html 4  
1 FORM 4 wk-form4_1750109427.xml 4 4033
  Complete submission text file 0001628280-25-031646.txt   5464
Mailing Address C/O ALPHASIMPLEX GROUP, LLC ONE CAMBRIDGE CENTER, 9TH FLOOR CAMBRIDGE MA 02142
Business Address
Lo Andrew (Reporting) CIK: 0001679076 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39781 | Film No.: 251051208

Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Issuer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)